SCHEMBL2808652

SCHEMBL2808652

C/C(=C\Sc1ccc(C)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
LMNA P02545 6/20 0.47
NPSR1 Q6W5P4 4/20 0.47
MAPT P10636 4/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
TDP1 Q9NUW8 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
AKR1C3 P42330 1/20 0.38
HPGD P15428 6/20 0.36
HTT P42858 3/20 0.36
PKM P14618 2/20 0.36
ATM Q13315 2/20 0.36
NLRP1 Q9C000 1/20 0.36
NTSR1 P30989 1/20 0.36
THRB P10828 1/20 0.36
CES2 O00748 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808655 1.00 ALDH1A1 (0.47) ALDH1A1LMNANPSR1MAPTKMT2A
SCHEMBL2812007 0.84 AKR1C3 (0.50) ALDH1A1LMNANPSR1MAPTKMT2A
SCHEMBL2812008 0.84 AKR1C3 (0.50) ALDH1A1LMNANPSR1MAPTKMT2A
SCHEMBL2808944 0.83 AKR1C3 (0.37) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL2808943 0.83 AKR1C3 (0.37) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL2812162 0.83 CYP2C9 (0.43) ALDH1A1LMNANPSR1MAPTKMT2A
SCHEMBL2812164 0.83 CYP2C9 (0.43) ALDH1A1LMNANPSR1MAPTKMT2A
SCHEMBL12851418 0.80 ALDH1A1 (0.42) ALDH1A1LMNANPSR1MAPTKMT2A
SCHEMBL2809764 0.78 TDP1 (0.55) ALDH1A1MAPTKMT2AMEN1TDP1
SCHEMBL2809761 0.78 TDP1 (0.55) ALDH1A1MAPTKMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 ALDH1A1 405/4885LMNA 2201/4885NPSR1 967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.